MML Investors Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
PF
DC
GS
GAM
NAM
PWA
MML Investors Services's SBIO Position: Q1 2025 in Review
MML Investors Services sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2025, closing a stake of 9,487 shares — an estimated $313K sold.
MML Investors Services first reported a position in SBIO in Q1 2018 and held it in 15 quarters. The position peaked at $669K in Q2 2021. 34 funds tracked by Wall St. Rank hold SBIO as of Q1 2025.
- MML Investors Services reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2025 after selling out during the quarter.
- MML Investors Services sold 9,487 ALPS Medical Breakthroughs ETF shares in Q1 2025, an estimated $313K.
- MML Investors Services first reported a position in ALPS Medical Breakthroughs ETF in Q1 2018 and held it in 15 quarters.
- MML Investors Services's ALPS Medical Breakthroughs ETF position peaked at $669K in Q2 2021.
- 34 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2025.
Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.